Registration Cancellation, Changes and Substitution Policy
All registration cancellations and changes require written notification to conference organizer info@gslsymposium.com.
Cancellation
Registration cancellations received by November 22 will receive a full refund minus a $100 processing fee. Cancellations received November 23 through December 13 will receive a 50% refund minus a $100 processing fee. No refunds will be given for cancellations made after December 13.
All registration cancellations and refunds will be processed in the same manner as original payment. If paid by credit card, the refund will be issued to the card on record, generally within 7-14 business days of the request. Canceling your conference registration does not automatically cancel your hotel reservation.
Substitution
Substitution requests for in-person registrations must be made in writing and submitted by the person who paid for the registration or by the original registrant by 5:00 PM ET on Monday, January 13. Requests may be sent via email to info@gslsymposium.com. No substitutions will be honored onsite.
Code of Conduct
GSLS is committed to providing a safe, professional, and welcoming meeting environment for all participants. All participants, including, but not limited to, attendees, speakers, exhibitors, supporters, staff, service providers, and others are expected to abide by this Code of Conduct Policy. This Policy applies to all components of the GSLS, including those sponsored by organizations other than the GSLS but held in conjunction with the meeting.
GSLS defines unacceptable behavior in the following ways, including but not limited to:
Any participant who feels unsafe or experiences unwelcome conduct, observes or experiences unacceptable behavior, or believes there has been a violation of this Policy is encouraged to report the incident immediately to Amanda Barton, VP, Operations, at amanda.barton@conexiant.com, so that the appropriate action can be taken. No concern is too small—if you see or hear something, we encourage you to say something.
Consequences of Reported Unacceptable Behavior
GSLS reserves the right to take any action deemed necessary and appropriate in response to any incident of unacceptable behavior, including the immediate removal of the offending party from the meeting without warning or refund. GSLS also reserves the right to prohibit the offending party’s attendance at any future virtual or in-person meetings.
Personal Data Collection
By registering for and participating in GSLS, you agree that the conference organizer will collect your personal data and potentially share it with technology partners, and Conexiant (formerly BroadcastMed) for the purposes of (but not limited to) marketing, online leads, emails, and/or awarding continuing education (CE) credits where applicable.
Personal Data Security
GSLS staff work diligently to provide a comfortable and secure environment during the registration process and meeting. We are committed to ensuring the personal data of all conference participants is encrypted and secure.
Photography, Videography, and Audio Recordings of Sessions
Photos, videos, and audio recordings may not be taken during the presentations without permission from the speaker. Reproducing and distributing session content is strictly prohibited.
Be Well Policy and Liability Waiver
As a condition of my participation in this meeting or event, I hereby waive any claim I may have against Conexiant (formerly BroadcastMed), and their officers, directors, employees, and agents, and release Conexiant (formerly BroadcastMed) and their officers, directors, employees, and agents from and against any and all liability for damage or injury that may arise from my participation or attendance at the program. I acknowledge that traveling to and in-person participation in GSLS events and activities brings some risk, and I do hereby assume responsibility for my own well-being. If another individual participates in my place per the GSLS transfer policy, the new registrant agrees to this disclaimer and waiver by default of transfer.
I understand that travel and gathering involves risk of sickness, including sickness from COVID-19. I waive and release Conexiant (formerly BroadcastMed), their sponsors and exhibitors, and their officers, directors, employees, and agents, from and against claims, liabilities and expenses arising from injury, sickness or death from contraction or spread of COVID-19 or other communicable disease due to travel to or attendance at an event sponsored by Conexiant (formerly BroadcastMed).
I will take necessary precautions while at the event including, but not limited to, engaging in appropriate social distancing, wearing a mask when requested and/or required, minimizing face touching, frequently washing hands and avoiding risky environments such as overcrowded bars or restaurants. I agree to not attend any Conexiant (formerly BroadcastMed) event if I feel ill or had recent exposure to an individual known to test positive for, or exhibiting symptoms of, COVID-19.
This waiver and release is binding on me and my heirs and successors.
Media Waiver
GSLS intends to take photographs and videos of this event for use in promotional materials, in print, electronic, and other media, including the GSLS website. By participating in this event, I grant that GSLS/Conexiant (formerly BroadcastMed) has the right to use any image, photograph, voice, or likeness, without limitation, in its promotional materials and publicity efforts without compensation. All media become the property of GSLS. Media may be displayed, distributed, or used by GSLS for any purpose.
Medical Information Disclaimer
Discussions, views, opinions, and recommendations as to medical procedures, products, choice of drugs, and drug dosages are the responsibility of GSLS presenters or supporters. Conexiant (Formerly BroadcastMed), and their respective employees, officers, and agents, accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement. Because of rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should be made. New methods and techniques involving drug usage described during this activity should be followed only in conjunction with the drug manufacturer's own published literature.
Privacy Policy
Please read this Privacy Policy carefully so that you can understand how we treat and process your personal information. By using this website, you acknowledge and agree to be bound by the terms of this policy. If you do not agree to this policy, then do not access or use this website.
All content available through Conexiant’s services and network, including but not limited to text, graphics, logos, icons, images, audio clips, digital downloads, data compilations, and software, is the property of Conexiant or its content suppliers and protected by the United States of America international copyright laws. Conexiant expressly reserves all intellectual property rights in all text, programs, products, processes, technology, content, and other materials which appear on this service. Access to this service does not confer and shall not be considered as conferring upon anyone any license under any of Conexiant’s or any third party's intellectual property rights.
The use of any content on Conexiant’s platform, network, or journals except as provided in these terms and conditions or with the express written consent of the content owner, is strictly prohibited. This includes, but is not limited to, the prohibition of reproducing, modifying, distributing, transmitting, republishing, displaying, or performing the content for public or commercial purposes, as well as the use of any such content on any other website, in a networked computer environment, or in any other medium for any purpose.
Click here to view the full Privacy Policy.